Moreover, expression of CCL2 induced by radiotherapy mediates the recruitment of CCR2+ Tregs in a mouse model of head and neck squamous cell carcinoma, thus diminishing the efficacy of radiotherapy, indicating that CCL2 may be a potential target to improve the efficacy of radiotherapy [91]. The gene discussed is CCL2; the disease is head and neck squamous cell carcinoma.